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Protocol
========

1. Preparation of stock solutions
---------------------------------

1.  Prepare calcium-free buffer (140 mM NaCl, 5 mM KCl, 1 mM MgCl~2~, 0.5 mM EGTA, 10 mM glucose in 10 mM HEPES-KOH, (pH 7.35)).

2.  Solubilize FURA-2 AM in DMSO to obtain an 1 mM stock solution. Mix using a vortex until the solution is homogenously light yellow. Protect cup from light. Dilute the FURA-2 AM stock solution into 1 ml Dulbecco\'s modified eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin to a final concentration of 4 μM for loading of HeLa cells.

3.  Prepare a 12.5 mM puromycin stock solution in distilled water (pH 7.0). Store aliquots at -20°C. Dilute the 12.5 mM puromycin stock solution in the calcium-free buffer to a final concentration of 500 μM puromycin.

4.  Dissolve thapsigargin in DMSO to obtain a 1 mM Stock solution.

5.  Solubilize 1 mg ophiobolin A in 20 μl chloroform and, subsequently, mix with 25 μl DMSO. The microcentrifuge tube remains open until chloroform is evaporated. Thus the final ophiobolin A concentration is 100 mM. Store aliquots at -20 °C. Prior to use, dilute stock solutions into calcium-free buffer to a final concentration of 100 μM. Thus, final DMSO concentration for live cell imaging does not exceed 0.1%.

6.  Dissolve trifluoperazine in DMSO to a concentration of 10 mM and store aliquots at -20 °C. Dilute stock solutions into calcium-free buffer to a final concentration of 10 μM prior to use. Thus final DMSO concentration for live cell imaging, like for ophiobolin A, does not exceed 0.1%.

7.  Dissolve the siRNAs (*SEC61A1* siRNA, *SEC61A1-UTR* siRNA and control siRNA) in RNase free water to prepare a 20 μM stock solution. Mix using a vortex and observe solubilization by eye. Store 50 μl aliquots at -20 °C.

2. Gene silencing in HeLa cells
-------------------------------

In order to study the contribution of a certain protein to ER Ca^2+^ efflux, the respective gene has to be efficiently silenced with two different siRNAs **(Fig. 1)**. In addition, the effect of silencing has to be overcome by expression of the respective wild type gene. Typically we use siRNAs that are directed against the coding and non-coding (UTR) region, respectively, of the gene of interest. Employing UTR-directed siRNA provides a convenient way for complementation.

1.  Seed 5.2 x 10^5^ HeLa cells (ATCC no. CCL-2) in a 6 cm culture dish with a 25 mm cover slip (pre-treated with 200 μl of poly-L-lysine (1 mg/ml) for 1 h) in Dulbecco\'s modified eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin and incubate at 37°C in a humidified environment with 5% CO~2~ (final volume 3.9 ml).

2.  Transfect the cells with *SEC61A1* siRNA, *SEC61A1*-UTR siRNA, or a negative control siRNA using HiPerFect Reagent according to the manufacturer's instructions (final concentration of siRNA: 20 nM). Briefly, prepare siRNAs freshly in a separate microcentrifuge tube prior to the actual transfection procedure: Add 20 μl HiPerFect transfection reagent to 4 μl of each siRNA (20 μM) that is dissolved in 80 μl of OptiMEM. This mix is gently vortexed and incubated at room temperature for 10 min. Add the siRNA mix (104 μl) dropwise to the seeded 5.2 x 10^5^ HeLa cells (3.9 ml).

3.  After 24 h, change the medium (3.9 ml) and transfect the cells for a second time with the same siRNA mix (104 μl).

4.  Evaluate silencing by Western blot analysis. It should be above 80%. Wash cells from the cell culture dish in phosphate-buffered saline (PBS) and harvest them in DMEM. Count the cells by employing the Countess Automated Cell Counter. Lyse the cells in cell lysis buffer (10 mM NaCl, 10 mM Tris-HCl, pH 8.0, 3 mM MgCl~2~, 0,5% NP40) supplemented with a protease-inhibitor cocktail (3 μg/ml Pepstatin A, 3 μg/ml Leupeptin, 3 μg/ml Antipain, 3 μg/ml Chymastatin) and mix with SDS-sample buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 10% Glycerol, 5% β-mercaptoethanol, 0.01% bromphenol blue) to obtain a final concentration of 10.000 cells/μl. Heat samples at 56 °C for 15 min and, subsequently, add some glas beads and vortex for 20 min to fragment DNA. Separate 20 μl of each sample by a Laemmli-type SDS-PAGE (typically 15% polyacrylamid for the separating gel). Transfer separated proteins onto a PVDF membrane by electroblotting ("wet-blot") at constant 400 mA for 3 h or overnight in transfer buffer (100 mM Glycin, 12.5 mM Tris-HCl). Afterwards, block with 5% (w/v) low fat dried milk in PBS for 30 min at room temperature and then expose the blot to the primary antibody directed against the C-terminus of Sec61α from rabbit and an anti-β-actin-antibody from mouse. Wash the blot in PBS-TritonX-100 (0.05%) and twice in PBS for 5 min, respectively. Visualize the primary antibodies using ECL Plex goat-anti-rabbit IgG-Cy5- or ECL Plex goat-anti-mouse IgG-Cy3-conjugate and the Typhoon-Trio imaging system in combination with the Image Quant TL software 7.0. In the case of the **SEC61A1** gene, the maximum silencing effect is typically seen 96 h after the first transfection. A representative experiment is shown in **Fig. 2.**

3. Complementation of HeLa cells
--------------------------------

In order to rescue the phenotype of *SEC61A1* silencing, the *SEC61A1* cDNA was inserted into the multiple cloning site (MCS) of a pCDNA3-internal ribosomal entry site (IRES)-GFP-vector that contained the cytomegalovirus (CMV) promoter, the MCS, the IRES, plus the green fluoresecent protein (GFP) coding sequence.

1.  48 h after the first siRNA transfection, exchange the medium (3.9 ml) for a second time and transform the cells with either empty vector or *SEC61A1* expression plasmid using Fugene HD according to the manufacturer's protocol (final ratio of vector to Fugene HD is 4 μg vector to 16 μl Fugene HD). Briefly, prepare plasmids freshly in a separate microcentrifuge tube prior to the transformation procedure: Add 16 μl Fugene HD transformation reagent to 4 μg of each plasmid that is dissolved in 80 μl of OptiMEM. Gently vortex this mix and incubate at room temperature for 10 min. Add the plasmid mix (0.1 ml) dropwise to the seeded 5.2 x 10^5^ HeLa cells (3.9 ml).

2.  After 48 h of plasmid expression, subject culture dishes to fluorescence microscopy prior to calcium imaging and harvesting. If necessary replace DMEM by PBS for better fluorescence signals. Record fluorescence images on a fluorescence microscope equipped with cooled CCD camera. Transformation efficiency can be determined by dividing the number of cells displaying GFP fluorescence by cells counted in the brightfield mode and should be above 80%. A typical result is shown in **Fig. 3.**

4. Live cell calcium imaging
----------------------------

1.  Prior to measurement, transfer the cover slip coated with transfected HeLa cells in a separate 3.5 cm culture dish. Load the cells with 4 μM FURA-2 AM in 1 ml DMEM for 45 min at 25°C in the dark^11,12^.

2.  Fix a 25 mm cover slip in the iMIC metal chamber and wash cells twice and incubate in a calcium-free buffer (each time 300 μl).

3.  Start collecting data on an iMIC microscope with polychrome V by alternately exciting at 340 nm and 380 nm and measuring the emitted fluorescence at 510 nm (Filter set: beamsplitter, 565 nm; emitter, 605/70 nm). Sample images containing 20-50 cells/frame every 3 s. Record FURA-2 signals as the ratios F340/F380, where F340 and F380 correspond to the background-subtracted fluorescence intensity at 340 and 380 nm, respectively.

4.  After 1 min, treat cells with puromycin (500 μM) in calcium-free buffer or with the same buffer. Alternatively, treat cells with a small molecule inhibitor (such as 10 μM trifluoperazine or 100 μM ophibolin A) or with the calcium-free buffer.

5.  After ratiometric measurements are carried out for 2 or 10 min, add thapsigargin (1 μM) and continue the measurements.

6.  Eventually, cytoslic \[Ca^2+^\] is estimated from ratio measurements by an established calibration method.^2^ Analyze data by Excel 2007 and Origin 6.1.

5. Representative Results:
--------------------------

So far, we addressed the question of whether silencing of the *SEC61A1* gene affects calcium (Ca^2+^) leakage from the ER (Fig. 1). The *SEC61A1* gene was silenced by two different siRNAs in HeLa cells for 96 hours. While silencing hardly affected cell growth and viability, protein transport into the ER of semi-permeabilized cells was almost completely inhibited. Furthermore, the *SEC61A1* silenced cells were severely affected with respect to Ca^2+^ leakage from the ER. The effect of gene silencing was reversed by expression of the *SEC61A1* gene. Thus, Sec61 complexes that are present in the ER membrane of all nucleated cells form Ca^2+^ leak channels that can be expected to play a crucial role in Ca^2+^ homeostasis. However, the presence of large, water-filled pores with uncontrolled ion permeability, as formed by Sec61 complexes in the ER membrane, would seriously interfere with the regulated release of Ca^2+^ from the ER lumen into the cytosol, an essential mechanism for intracellular signalling. We identified a calmodulin (CaM) binding motif in the cytosolic N-terminus of mammalian Sec61α that bound CaM but not Ca^2+^-free apocalmodulin with nanomolar affinity and sequence specificity. At the cellular level, two different CaM antagonists stimulated Ca^2+^ release from the ER in the presence but not in the absence of Sec61 channels (**Figs 4 and 5**). The latter was not observed when Sec61 channels were present that contained mutations in the IQ motif of Sec61α. Thus, Ca^2+^-CaM is involved in limiting Ca^2+^ leakage from the ER (**Fig. 6**).

**Figure 1**. Flow chart. See text for details.

**Figure 2.** Data analysis for silencing efficiency. Silencing was evaluated by Western-blot analysis using antibodies that were directed against Sec61α and β-actin (loading control). The primary antibodies were visualized by using ECL Plex secondary antibodies and fluorescence imaging.

**Figure 3.** Data analysis for transfection efficiency. Images were recorded on a fluorescence microscope equipped with cooled CCD camera. Transformation efficiency can be determined by dividing the number of cells displaying GFP fluorescence by cells counted in the brightfield mode.

**Figure 4.** Screen shots from live cell calcium imaging of HeLa cells in the presence of control- or *SEC61A1*-siRNA and the presence or absence of the CaM-antagonist ophiobolin A. HeLa cells were treated with siRNA directed against *SEC61A1* (B) or a negative control siRNA (A) for 96 h as indicated. These cells were loaded with the calcium indicator FURA-2 AM and incubated in a Ca^2+^ free buffer containing 0.5 mM EGTA, then buffer or ophiobolin A (Ophio A) in buffer was added and the incubation resumed. After 10 min, Ca^2+^ release was initiated by applying thapsigargin (TG) in the absence of external Ca^2+^ and the incubation was continued. Screen shots from the continuous calcium imaging were taken at the indicated times.

**Figure 5.** Data analysis for live cell calcium imaging experiments. (A) Kinetic and quantitative analysis of a series of experiments as depicted in **Fig. 4A**. Cytoslic \[Ca^2+^\] was estimated from ratio measurements by an established calibration method^2^. The effect of thapsigargin is shown as bar diagram. (B-D) Cells were treated with control siRNA or the indicated *SEC61A1*-siRNA for 48 h and then transformed with either control vector (C), or *SEC61A1* expression plasmid (C), or mutant *SEC61A1* expression plasmid (D) as indicated. After 48 h, calcium imaging experiments were carried out as in **Figs 4 and 5A**. Statistical analysis of the changes in the cytosolic Ca^2+^ concentration after the addition of thapsigargin in experiments such as presented in A are shown. P values \< 0.001 were defined as significant by unpaired t test and are indicated by three asterisks (\*\*\*), n.s., not significant. The numbers of cells that were analyzed are indicated. Average values are given, error bars represent standard errors of the means (s.e.m.). We note that these examples were adapted from ref. 13.

**Figure 6.** These data indicate that the release of nascent chains from the Sec61 complex indeed leads to calcium release from the ER and the formation of a calcium nanodomain around the cytosolic mouth of the Sec61 complex. This calcium is bound by calmodulin and calcium-calmodulin closes the Sec61 complex."

Discussion
==========

In mammalian cells, the endoplasmic reticulum (ER) plays a key role in protein biogenesis as well as in calcium signalling. Here, we have described an experimental system that allows us to directly address the role of one potential Ca^2+^ leak channel and to characterize its putative regulatory mechanisms^13^. This experimental system gives us the unique opportunities to i) evaluate the contribution of different ER membrane proteins to passive Ca^2+^ efflux from the ER in various cell types, ii) characterize the proteins and mechanisms that limit this passive Ca^2+^ efflux, and iii) study the effects of disease linked mutations in the relevant components.

We note that only viable cells should be analyzed and that overall viability should be above 80%. Therefore, cell viability is routinely evaluated employing Nuclear-ID blue/green cell viability reagent according to the manufacturer's protocol. Furthermore, statistical analysis of the changes in the cytosolic Ca^2+^ concentration is mandatory. Therefore, the experiments have to be carried out for four different batches of cells and two coverslips with at least 20 cells have to be analyzed for each condition in a single experiment. We note that the various experiments have to be carried out at the same time after seeding on the cover slips.
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